Cationic cyanato and thiocyanato complexes useful as radiodiagnostic agents

Claim 2

A kit in accord with claim 1 having a first vial containing said organic ligand and a second vial containing said cyanate or thiocyanate ion.

Claim 3

A kit in accord with claim 1 wherein said organic ligand is present in the form of a lyophilized acid salt.

Claim 4

A kit in accord with claim 3 wherein said lyophilized acid salt and a cyanate or thiocyanate ion in solid form are present in one vial.

Claim 5

A kit in accord with claim 4 wherein said vial and its contents are sterilized.

Claim 6

A kit in accord with claim 3 wherein said ligand acid salt is a normally solid, hydrophilic compound capable of binding with Tc-99m to form a cationic complex and having a formula selected from: or wherein: R , R ', R",R"', R l, R 2 , R3, R4, R5, R 6, R 21 , R 22 and R 23 are each independently selected from hydrogen ; or substituted or unsubstituted alkyl, alkylene, aryl, alkylaryl, arylalkyl, monocycloalkyl, polycycloalkyl, heterocyclic and carbocyclic group; and R plus R i in formula (A) may be taken together to form a cyclic compound; A, A' , A", A l, A 2, A3, A4, A 5 and A 6 are independently selected donor atoms, each having a free electron pair available for accepting a proton to provide a charged ligand and having the capability of complexing with Tc-99m to form a cationic complex; B is an atom selected from the group of donor atoms having a pair of electrons for complexing with Tc-99m or Tc-99, boron or from the elements listed in Group IV A of the periodic table; yl, y2, y3, Y 4 , Y 5 and Y 6 are each independently selected from hydrogen; or substituted or unsubstituted alkyl, alkylene, aryl, alkylaryl, arylalkyl, monocycloalkyl, polycycloalkyl, heterocyclic and carbocyclic groups; X and X' are saturated or unsaturated alkyl groups; Z is an anion; i is an integer from 1 to 6; j, j' and j" are each independently 0 or 1; k l, k2, k3, k 4 , k 5 and k 6 are each independently 0 or 1; n, n' and n" are each independently the integer 1 or 2; n 1 , n 2 , n 3 , n 4 , n 5 , n 6 , are independently 0 or 1; n 7 and n 8 are each an integer from 1 to 6 ; n 9 , n 10 , n ll and n 12 are each an integer from 1 to 3 ; m is 0 or 1; r', r" and r" ' are independently 0 or 1; and t and t' are independently 0 or 1.

Claim 7

The kit of claim 6 having the formula: wherein R is ethyl or phenyl, A is phosporous or arsenic, and R' is a lower alkyl group having from 1 to about 6 carbon atoms.

Claim 8

The kit of claim 7 wherein Z is bisulfate, biphosphate, or tetrafluoroborate.

Claim 9

The kit of claim 6 wherein Z is derived from sulfuric acid, phosphoric acid, perchloric acid, nitric acid or boric acid.

Claim 10

The kit of claim 6 wherein A is selected from the group consisting of P, As, N, 0, S, Sb, Se and Te.

Claim 11

The kit of claim 6 wherein said ligand acid salt has the formula: wherein A is P or As ; and each R is independently H, a lower alkyl group having from 1 to about 6 carbon atoms, or phenyl.

Claim 12

The compound of claim 11 wherein Z is bisulfate, biphosphate, nitrate, tetrafluoroborate or perchlorate.

Claim 13

The kit of claim 11 wherein A is phosphorus.

Claim 14

The kit of claim 11 wherein A is phosphorous and R is methyl or ethyl.

Claim 15

The kit of claim 11 having the formula:

Claim 16

The kit of claim 6 wherein said ligand acid salt has the formula: wherein A is P or As; and each R is independently H, or a lower alkyl group having from 1 to about 6 carbon atoms.

Claim 17

The kit of claim 16 wherein Z is bisulfate, biphosphate, nitrate, tetrafluoroborate or perchlorate.

Claim 18

The kit of claim 16 wherein A is phosphorous.

Claim 19

The kit of claim 16 wherein A is phosphorus and R is methyl or ethyl.

Claim 20

The kit of claim 16 having the formula:

Claim 21

A kit in accord with claim 1 further comprising an accelerator.

Claim 23

The method in accord with claim 22 wherein said reacting step is carried out at a pH in the range of about 3.5 to 5.5.

Claim 24

The method in accord with claim 22 wherein said reacting step includes heating the reaction mixture.

Claim 25

The method in accord with claim 22 wherein said reacting step includes admixing said sodium pertechnetate, organic ligand and said cyanate or thiocyanate ion, and then heating said admixture.,

Claim 26

/ 26. The method in accord with claim 25 wherein said admixing step includes adjusting the pH in the range of about 3.5 to 5.5.

Claim 27

The method in accord with claim 22 wherein said reacting step includes (1) admixing said pertechnetate and said organic ligand in the presence of a halide ion to form an intermediate complex and (2) admixing a cyanate or thiocyanate ion with said intermediate complex and further heating to form a cyanato-technetium-ligand complex or a thiocyanato-technetium-ligand complex, respectively.

Claim 28

The method in accord with claim 27 wherein said second admixing step includes adjusting the pH in a range of about 3.5 to 5.5.

Claim 29

A cationic hepatobiliary radiodiagnostic agent made by reacting sodium pertechnetate with (a) an organic ligand having one or more donor atoms, each with a free-electron pair available for accepting a proton or for complexing with technetium to form a cationic complex and (b) a cyanate or a thiocyanate ion.

Claim 30

The radiodiagnostic agent in accord with claim 29 wherein said reacting step is carried out at a pH in the range of about 3.5 to 5.5.

Claim 31

The radiodiagnostic agent in accord with claim 29 wherein said reacting step includes heating the reaction mixture.

Claim 32

The radiodiagnostic agent in accord with claim 29 wherein said reacting step includes admixing said sodium pertechnetate, said organic ligand and said cyanate or thiocyanate ion, and then heating said admixture.

Claim 33

The radiodiagnostic agent in accord with claim 32 wherein said admixing step includes adjusting the pH in the range of about 3.5 to 5.5.

Claim 34

The radiodiagnostic agent in accord with claim 29 wherein said reacting step includes (1) admixing said pertechnetate and said organic ligand in the presence of a halide ion to form an intermediate complex and (2) admixing a cyanate or thiocyanate ion with said intermediate complex and further heating to form a cyanato-technetium-ligand complex or a thiocyanato-technetium-ligand complex, respectively.

Claim 35

3 5. The radiodiagnostic agent in accord with claim 34 wherein said second admixing step includes adjusting the pH in a range of about 3.5 to 5.5.